Sign up to save your podcasts
Or
Share STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tackle a pair of related topics: what the STEP HFpEF DM trial from ACC.24 means for the diabetes community and the need for fair and equitable allocation of incretin-based therapies in the face of ongoing drug shortages and overwhelming demand.
View all episodes
By Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
4.6
1010 ratings
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tackle a pair of related topics: what the STEP HFpEF DM trial from ACC.24 means for the diabetes community and the need for fair and equitable allocation of incretin-based therapies in the face of ongoing drug shortages and overwhelming demand.
More shows like Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
View all
NPR News Now
14,145 Listeners
Diabetes Core Update
96 Listeners
The Rich Roll Podcast
11,727 Listeners
Juicebox Podcast: Type 1 Diabetes
1,567 Listeners
Diabetes Connections | Type 1 Diabetes
217 Listeners
Hidden Brain
43,454 Listeners
AFP: American Family Physician Podcast
687 Listeners
The Curbsiders Internal Medicine Podcast
3,317 Listeners
Core IM | Internal Medicine Podcast
1,090 Listeners
The Peter Attia Drive
7,929 Listeners
Annals On Call Podcast
184 Listeners
The Huddle: Conversations with the Diabetes Care Team
37 Listeners
The Mel Robbins Podcast
20,884 Listeners
Diabetech - Diabetes Tech, Research, and News
38 Listeners
On The Pen With Dave Knapp
245 Listeners